CEFZON Side Effects

7011151-X | Cystitis Haemorrhagic
on Sep 16, 2010 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with upper respiratory tract inflammation, schizophrenia and was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis haemorrhagic. Cefzon dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), HALOSTEN (View Halosten Review and Halosten Label ), CONTOMIN (View Contomin Review and Contomin Label ), LANDSEN (View Landsen Review and Landsen Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), BENZALIN (View Benzalin Review and Benzalin Label ), TASMOLIN (View Tasmolin Review and Tasmolin Label ). Patient was hospitalized.

7003395-8 | Multi-organ Failure, Toxic Epidermal Necrolysis
Patient was taking Cefzon (View Usage). Patient had the following side effects: multi-organ failure, toxic epidermal necrolysis on Sep 10, 2010 from JAPAN Additional patient health information: Female patient , weighting 156.5 lb, was diagnosed with post procedural infection, gastritis and. Cefzon dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SIGMART (View Sigmart Review and Sigmart Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6974962-2 | Multi-organ Failure, Toxic Epidermal Necrolysis
Adverse event was reported on Aug 31, 2010 by a Female patient taking Cefzon (View Usage) (Dosage: ) . Location: JAPAN , 65 years of age, After Cefzon was administered, patient had the following side effects: multi-organ failure, toxic epidermal necrolysis. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ).

6958183-5 | Parotid Gland Enlargement, Pyrexia, Toxic Skin Eruption
on Aug 25, 2010 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with hordeolum, neck pain and was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: parotid gland enlargement, pyrexia, toxic skin eruption. Cefzon dosage: . During the same period patient was treated with EMPYNASE (View Empynase Review and Empynase Label ), PABRON S (Uid/qd) (View Pabron S Review and Pabron S Label ), LANDEL (View Landel Review and Landel Label ), TENORMIN (View Tenormin Review and Tenormin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.


6943392-1 | Cystitis Haemorrhagic
on Aug 16, 2010 Female patient from JAPAN , 55 years of age, weighting 103.6 lb, was diagnosed with upper respiratory tract inflammation and was treated with Cefzon (View Usage). Patient had the following side effects: cystitis haemorrhagic. Cefzon dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), LANDSEN (View Landsen Review and Landsen Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ). Patient was hospitalized.

6929023-5 | Nephritis
Patient was taking Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: nephritis on Aug 09, 2010 from JAPAN Additional patient health information: Male patient , child 3 years of age, was diagnosed with pneumonia streptococcal and. Cefzon dosage: .

6928794-1 | Histiocytosis Haematophagic, Stevens-johnson Syndrome
Adverse event was reported on Aug 04, 2010 by a Female patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: JAPAN , weighting 17.64 lb, Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic, stevens-johnson syndrome. During the same period patient was treated with FAROM (View Farom Review and Farom Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), ZITHROMAC (View Zithromac Review and Zithromac Label ), PACETCOOL (View Pacetcool Review and Pacetcool Label ). Patient was hospitalized.

6922897-3 | Erythema, Parotid Gland Enlargement, Pyrexia
on Aug 05, 2010 Female patient from JAPAN , 71 years of age, was treated with Cefzon (View Usage). Patient had the following side effects: erythema, parotid gland enlargement, pyrexia. Cefzon dosage: . During the same period patient was treated with EMPYNASE (View Empynase Review and Empynase Label ), PABRON S (View Pabron S Review and Pabron S Label ). Patient was hospitalized.

6858113-0 | Nephritis
on Jul 12, 2010 Male patient from JAPAN , child 3 years of age, was diagnosed with pneumonia streptococcal and was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: nephritis. Cefzon dosage: .

6843563-9 | Neutropenia, Overdose
Patient was taking Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, overdose on Jul 08, 2010 from JAPAN Additional patient health information: Male patient , 54 years of age, . Cefzon dosage: .

6824332-2 | Nephritis
Adverse event was reported on Jul 01, 2010 by a Male patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with pneumonia streptococcal and. Location: JAPAN , child 3 years of age, Patient had the following side effects: nephritis.

6779402-4 | Histiocytosis Haematophagic, Lymphocyte Stimulation Test Positive, Stevens-johnson Syndrome
on Jun 09, 2010 Female patient from JAPAN , weighting 17.64 lb, was diagnosed with infection (What is infection?) and was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: histiocytosis haematophagic, lymphocyte stimulation test positive, stevens-johnson syndrome. Cefzon dosage: . During the same period patient was treated with FAROM (View Farom Review and Farom Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), PACETCOOL (View Pacetcool Review and Pacetcool Label ). Patient was hospitalized.

6764318-X | Histiocytosis Haematophagic, Stevens-johnson Syndrome
on Jun 09, 2010 Female patient from JAPAN , weighting 17.64 lb, was diagnosed with infection (What is infection?) and was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic, stevens-johnson syndrome. Cefzon dosage: . During the same period patient was treated with FAROM (View Farom Review and Farom Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), PACETCOOL (View Pacetcool Review and Pacetcool Label ). Patient was hospitalized.

6763176-7 | Histiocytosis Haematophagic, Stevens-johnson Syndrome
Patient was taking Cefzon (View Usage). Patient had the following side effects: histiocytosis haematophagic, stevens-johnson syndrome on May 30, 2010 from JAPAN Additional patient health information: Female patient , weighting 17.64 lb, was diagnosed with infection (What is infection?) and. Cefzon dosage: . During the same period patient was treated with FAROM (View Farom Review and Farom Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), PACETCOOL (View Pacetcool Review and Pacetcool Label ). Patient was hospitalized.

6163782-7 | Pseudomembranous Colitis, Thirst
Adverse event was reported on Apr 15, 2009 by a Female patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with pyrexia, infection prophylaxis and. Location: JAPAN , weighting 99.21 lb, After Cefzon was administered, patient had the following side effects: pseudomembranous colitis, thirst. During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMLODINE (View Amlodine Review and Amlodine Label ), TANATRIL (View Tanatril Review and Tanatril Label ), GASTER (View Gaster Review and Gaster Label ), FERROMIA (View Ferromia Review and Ferromia Label ). Patient was hospitalized.

6148895-8 | Agranulocytosis
on Apr 01, 2009 Female patient from JAPAN , 77 years of age, was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis. Cefzon dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), EVISTA (View Evista Review and Evista Label ), OPALMON (View Opalmon Review and Opalmon Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), NEUROTROPIN (View Neurotropin Review and Neurotropin Label ), NEUROVITAN (View Neurovitan Review and Neurovitan Label ), NORPACE (View Norpace Review and Norpace Label ).

6127209-3 | Pseudomembranous Colitis, Thirst
on Mar 10, 2009 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with pyrexia, infection prophylaxis and was treated with Cefzon (View Usage). Patient had the following side effects: pseudomembranous colitis, thirst. Cefzon dosage: . During the same period patient was treated with CEFAZOLIN AND DEXTROSE (View Cefazolin And Dextrose Review and Cefazolin And Dextrose Label ), AMLODINE (View Amlodine Review and Amlodine Label ), TANATRIL (View Tanatril Review and Tanatril Label ), GASTER (View Gaster Review and Gaster Label ), FERROMIA (View Ferromia Review and Ferromia Label ). Patient was hospitalized.

6122705-7 | Liver Disorder
Patient was taking Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: liver disorder on Mar 10, 2009 from JAPAN Additional patient health information: Male patient , 63 years of age, . Cefzon dosage: .

6120139-2 | Pneumonia, Rash Pruritic
Adverse event was reported on Mar 11, 2009 by a Female patient taking Cefzon (View Usage) (Dosage: ) . Location: JAPAN , 70 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), rash pruritic. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), PURSENNID (View Pursennid Review and Pursennid Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SAIREI TO (View Sairei-to Review and Sairei-to Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ). Patient was hospitalized.

6119132-5 | Arthralgia, Tubulointerstitial Nephritis
on Mar 10, 2009 Female patient from JAPAN , 14 years of age, was treated with Cefzon (View Usage). Patient had the following side effects: arthralgia, tubulointerstitial nephritis. Cefzon dosage: . During the same period patient was treated with SERRAPEPTASE (View Serrapeptase Review and Serrapeptase Label ), LORATADINE (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

6108558-1 | Pseudomembranous Colitis, Thirst
on Mar 03, 2009 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with pyrexia and was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: pseudomembranous colitis, thirst. Cefzon dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMLODINE (View Amlodine Review and Amlodine Label ), TANATRIL (View Tanatril Review and Tanatril Label ), GASTER (View Gaster Review and Gaster Label ), FERROMIA (View Ferromia Review and Ferromia Label ). Patient was hospitalized.

6101587-3 | Arthralgia, Tubulointerstitial Nephritis
Patient was taking Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, tubulointerstitial nephritis on Feb 23, 2009 from JAPAN Additional patient health information: Female patient , 14 years of age, . Cefzon dosage: . During the same period patient was treated with SERRAPEPTASE (View Serrapeptase Review and Serrapeptase Label ), LORATADINE (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

6094521-6 | Pseudomembranous Colitis, Thirst
Adverse event was reported on Feb 19, 2009 by a Female patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with pyrexia and. Location: JAPAN , weighting 99.21 lb, Patient had the following side effects: pseudomembranous colitis, thirst. During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMLODINE (View Amlodine Review and Amlodine Label ), TANATRIL (View Tanatril Review and Tanatril Label ), GASTER (View Gaster Review and Gaster Label ), FERROMIA (View Ferromia Review and Ferromia Label ). Patient was hospitalized.

6087215-4 | Blood Immunoglobulin E Increased, Hepatic Function Abnormal
on Feb 13, 2009 Male patient from JAPAN , weighting 169.8 lb, was diagnosed with upper respiratory tract inflammation, pyrexia and was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: blood immunoglobulin e increased, hepatic function abnormal. Cefzon dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), TRANSAMIN (View Transamin Review and Transamin Label ), PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

6071713-3 | Blood Immunoglobulin E Increased, Hepatic Function Abnormal
on Feb 02, 2009 Male patient from JAPAN , weighting 169.8 lb, was diagnosed with upper respiratory tract inflammation, pyrexia and was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: blood immunoglobulin e increased, hepatic function abnormal. Cefzon dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), TRANSAMIN (View Transamin Review and Transamin Label ), PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

6070673-9 | Tubulointerstitial Nephritis
Patient was taking Cefzon (View Usage). Patient had the following side effects: tubulointerstitial nephritis on Feb 04, 2009 from JAPAN Additional patient health information: Female patient , 14 years of age, . Cefzon dosage: . Patient was hospitalized.

6061038-4 | Pseudomembranous Colitis
Adverse event was reported on Jan 29, 2009 by a Female patient taking Cefzon (View Usage) (Dosage: ) . Location: JAPAN , 90 years of age, After Cefzon was administered, patient had the following side effects: pseudomembranous colitis. During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TANATRIL (View Tanatril Review and Tanatril Label ). Patient was hospitalized.

6050776-5 | Liver Disorder
on Jan 16, 2009 Male patient from JAPAN , 63 years of age, was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Cefzon dosage: .

6050547-X | Blood Immunoglobulin E Increased, Hepatic Function Abnormal
on Jan 16, 2009 Male patient from JAPAN , weighting 169.8 lb, was diagnosed with upper respiratory tract inflammation, pyrexia and was treated with Cefzon (View Usage). Patient had the following side effects: blood immunoglobulin e increased, hepatic function abnormal. Cefzon dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), TRANSAMIN (View Transamin Review and Transamin Label ), PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

6036126-9 | Pneumonia, Rash Pruritic
Patient was taking Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: pneumonia (What is pneumonia?), rash pruritic on Jan 09, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, . Cefzon dosage: . During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), PURSENNID (View Pursennid Review and Pursennid Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SAIREI TO (View Sairei-to Review and Sairei-to Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ). Patient was hospitalized.

6028858-3 | Iritis, Rash Erythematous, Tubulointerstitial Nephritis
Adverse event was reported on Dec 30, 2008 by a Female patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with pyrexia, rash (What is rash?) and. Location: JAPAN , 31 years of age, Patient experienced the following unwanted or unexpected effects: iritis, rash erythematous, tubulointerstitial nephritis. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized and became disabled.

6027567-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
on Dec 26, 2008 Male patient from JAPAN , 20 years of age, was diagnosed with nasopharyngitis, pyrexia and was treated with Cefzon (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Cefzon dosage: . During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), TRANSAMIN (View Transamin Review and Transamin Label ), PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

6026926-3 | Pneumonia, Pruritus, Rash
on Dec 26, 2008 Female patient from JAPAN , 70 years of age, was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: pneumonia (What is pneumonia?), pruritus, rash (What is rash?). Cefzon dosage: . During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), PURSENNID (View Pursennid Review and Pursennid Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SAIREI TO (View Sairei-to Review and Sairei-to Label ). Patient was hospitalized.

5779269-7 | Oesophageal Atresia
Patient was taking Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal atresia on Jun 19, 2008 from JAPAN Additional patient health information: Male patient , weighting 4.72 lb, . Cefzon dosage: . During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), PIPERIDOLATE (View Piperidolate Review and Piperidolate Label ), DYDROGESTERONE TAB (View Dydrogesterone Tab Review and Dydrogesterone Tab Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), ISOXSUPRINE (View Isoxsuprine Review and Isoxsuprine Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ).

5779195-3 | Oesophageal Atresia
Adverse event was reported on Jun 19, 2008 by a Male patient taking Cefzon (View Usage) (Dosage: ) . Location: JAPAN , weighting 5.18 lb, Patient had the following side effects: oesophageal atresia. During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), PIPERIDOLATE (View Piperidolate Review and Piperidolate Label ), DYDROGESTERONE TAB (View Dydrogesterone Tab Review and Dydrogesterone Tab Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), ISOXSUPRINE (View Isoxsuprine Review and Isoxsuprine Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ).

5775671-8 | Convulsion, Dehydration
on Jun 09, 2008 Female patient from , 33 years of age, was diagnosed with thermal burn and was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: convulsion, dehydration. Cefzon dosage: . During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), CLOMIPRAMINE HYDROCHLORIDE (View Clomipramine Hydrochloride Review and Clomipramine Hydrochloride Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), RILMAZAFONE (View Rilmazafone Review and Rilmazafone Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CHLORPROMAZINE HYDROCHLORIDE (View Chlorpromazine Hydrochloride Review and Chlorpromazine Hydrochloride Label ), LORMETAZEPAM (View Lormetazepam Review and Lormetazepam Label ).

5766867-X | Oesophageal Atresia
on Jun 05, 2008 Male patient from JAPAN , weighting 4.72 lb, was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal atresia. Cefzon dosage: . During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ).

5765751-5 | Oesophageal Atresia
Patient was taking Cefzon (View Usage). Patient had the following side effects: oesophageal atresia on Jun 05, 2008 from JAPAN Additional patient health information: Male patient , weighting 5.18 lb, . Cefzon dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ).

5753789-3 | Pulmonary Valve Stenosis, Toxic Epidermal Necrolysis
Adverse event was reported on May 28, 2008 by a Female patient taking Cefzon (View Usage) (Dosage: ) . Location: , 23 years of age, After Cefzon was administered, patient had the following side effects: pulmonary valve stenosis, toxic epidermal necrolysis. During the same period patient was treated with LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), TEPRENONE (View Teprenone Review and Teprenone Label ).

5738958-0 | Eye Discharge, Ocular Hyperaemia, Oral Intake Reduced, Pyrexia, Stevens-johnson Syndrome
on May 07, 2008 Female patient from JAPAN , weighting 72.53 lb, was diagnosed with nasopharyngitis and was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: eye discharge, ocular hyperaemia, oral intake reduced, pyrexia, stevens-johnson syndrome. Cefzon dosage: . During the same period patient was treated with PL GRAN. (View Pl Gran. Review and Pl Gran. Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), KAKKON TO (View Kakkon-to Review and Kakkon-to Label ), ALDIOXA (View Aldioxa Review and Aldioxa Label ), SODIUM GUALENATE (View Sodium Gualenate Review and Sodium Gualenate Label ). Patient was hospitalized.

5727864-3 | Bone Marrow Failure, Leukocytoclastic Vasculitis
on Apr 25, 2008 Female patient from JAPAN , 66 years of age, was diagnosed with prophylaxis, lymph gland infection and was treated with Cefzon (View Usage). Patient had the following side effects: bone marrow failure, leukocytoclastic vasculitis. Cefzon dosage: . During the same period patient was treated with THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

5718486-9 | Bone Marrow Failure, Hypersensitivity
Patient was taking Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: bone marrow failure, hypersensitivity on Apr 17, 2008 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with prophylaxis, lymph gland infection and. Cefzon dosage: . During the same period patient was treated with THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ), CARBOCISTEINE (View Carbocisteine Review and Carbocisteine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

5700105-9 | Arthralgia, Gait Disturbance, Liver Disorder, Muscular Weakness, Myalgia, Oedema Peripheral, Pyrexia
Adverse event was reported on Apr 02, 2008 by a Female patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with pharyngitis and. Location: JAPAN , weighting 141.1 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, gait disturbance, liver disorder, muscular weakness, myalgia, oedema peripheral, pyrexia. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5695173-7 | Atrioventricular Block Second Degree, Bradyarrhythmia
on Mar 25, 2008 Female patient from , 72 years of age, was treated with Cefzon (View Usage). Patient had the following side effects: atrioventricular block second degree, bradyarrhythmia. Cefzon dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

5693601-4 | Arthralgia, Gait Disturbance, Liver Disorder, Muscular Weakness, Oedema Peripheral, Pyrexia
on Mar 27, 2008 Female patient from JAPAN , weighting 141.1 lb, was diagnosed with pharyngitis and was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: arthralgia, gait disturbance, liver disorder, muscular weakness, oedema peripheral, pyrexia. Cefzon dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5693580-X | Arthralgia, Gait Disturbance, Liver Disorder, Muscular Weakness, Myalgia, Oedema Peripheral, Pyrexia
Patient was taking Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, gait disturbance, liver disorder, muscular weakness, myalgia, oedema peripheral, pyrexia on Mar 24, 2008 from JAPAN Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with pharyngitis and. Cefzon dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5683376-7 | Eye Discharge, Ocular Hyperaemia, Oral Intake Reduced, Pyrexia, Stevens-johnson Syndrome
Adverse event was reported on Mar 20, 2008 by a Female patient taking Cefzon (View Usage) (Dosage: ) was diagnosed with nasopharyngitis and. Location: JAPAN , weighting 72.53 lb, Patient had the following side effects: eye discharge, ocular hyperaemia, oral intake reduced, pyrexia, stevens-johnson syndrome. During the same period patient was treated with PL GRAN. (View Pl Gran. Review and Pl Gran. Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), KAKKON TO (View Kakkon-to Review and Kakkon-to Label ), ALDIOXA (View Aldioxa Review and Aldioxa Label ), SODIUM GUALENATE (View Sodium Gualenate Review and Sodium Gualenate Label ). Patient was hospitalized.

5675646-3 | Arthralgia, Gait Disturbance, Hepatic Function Abnormal, Myalgia, Oedema Peripheral, Swelling
on Mar 14, 2008 Female patient from JAPAN , 48 years of age, was treated with Cefzon (View Usage). After Cefzon was administered, patient had the following side effects: arthralgia, gait disturbance, hepatic function abnormal, myalgia, oedema peripheral, swelling. Cefzon dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5670964-7 | Eye Discharge, Ocular Hyperaemia, Oral Intake Reduced, Pyrexia, Stevens-johnson Syndrome
on Mar 13, 2008 Female patient from JAPAN , weighting 72.53 lb, was diagnosed with nasopharyngitis and was treated with Cefzon (View Usage). Patient experienced the following unwanted or unexpected effects: eye discharge, ocular hyperaemia, oral intake reduced, pyrexia, stevens-johnson syndrome. Cefzon dosage: . During the same period patient was treated with PL GRAN. (View Pl Gran. Review and Pl Gran. Label ), CEFPODOXIME PROXETIL (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), KAKKON TO (View Kakkon-to Review and Kakkon-to Label ), ALDIOXA (View Aldioxa Review and Aldioxa Label ), SODIUM GUALENATE (View Sodium Gualenate Review and Sodium Gualenate Label ). Patient was hospitalized.

5664807-5 | Bradyarrhythmia
Patient was taking Cefzon (View Usage). Patient had the following side effects: bradyarrhythmia on Mar 06, 2008 from Additional patient health information: Female patient , 72 years of age, . Cefzon dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.